BBIO Greek Exposure

BBIO is BRIDGEBIO PHARMA, a Healthcare company with a $15.25B market cap. Gamma (GEX) highlights support/resistance from dealer hedging, Delta (DEX) shows bullish vs bearish bets, Vanna tracks volatility-driven flows, and Charm shows time-decay hedging. Analyze exposure by strike and expiration to find key price levels.

Name
BRIDGEBIO PHARMA
Type
Common Stock
Sector
Healthcare
Market cap
$15.25B
Avg. daily volume (30d)
2.96M
Next earnings
2027-02-23

Frequently asked questions

What is BBIO gamma exposure (GEX)?
Gamma exposure (GEX) measures how much market makers must hedge when BBIO stock moves. Positive GEX means dealers are long gamma and will hedge in a stabilizing way (buy dips, sell rallies), while negative GEX means their hedging amplifies moves.
What is BBIO delta exposure (DEX)?
Delta exposure (DEX) shows the net directional options exposure on BBIO. It represents how many shares market makers need to buy or sell to stay delta-neutral. Large DEX shifts can indicate significant directional positioning.
How do BBIO Vanna and Charm affect the stock?
Vanna measures how BBIO option deltas change with implied volatility — when IV drops, positive vanna exposure forces dealers to buy shares, creating upward pressure. Charm measures delta decay over time, causing similar hedging flows as options approach expiration.